Literature DB >> 16823016

Quality of life and psychological status of patients with implantable cardioverter defibrillators.

Sue Ann Thomas1, Erika Friedmann, Chi-Wen Kao, Pia Inguito, Matthew Metcalf, Frances J Kelley, Steven S Gottlieb.   

Abstract

BACKGROUND: Implantable cardioverter defibrillators reduce mortality in patients at high risk for sudden cardiac death and in patients with heart failure. Patients with defibrillators often experience psychological distress and poor quality of life, which can potentiate pathological processes that increase the risk for sudden cardiac death. To achieve the full benefits of the defibrillators, patients must maintain their psychological status and quality of life.
OBJECTIVES: To review the research on psychological status and quality of life of patients with implantable cardioverter defibrillators and suggest nursing interventions to improve the patients' health.
METHOD: Searches of PubMed were used to find articles on depression, anxiety, and quality of life in patients with implantable cardioverter defibrillators.
RESULTS: Poor quality of life is associated with anxiety and depression in patients with implantable cardioverter defibrillators. Discharges of the devices have adverse consequences for patients' psychological status and quality of life. Younger patients are at highest risk for psychological distress and poor quality of life after implantation. Longitudinal research would facilitate determining the course of the changes in psychological status and quality of life during the time patients have the defibrillators. More intensive intervention may be necessary for the most vulnerable recipients: patients who are young, have experienced shocks, and are in psychological distress.
CONCLUSIONS: Poor quality of life and depression are common in patients with implantable cardioverter defibrillators. Nursing interventions to reduce psychological distress and improve quality of life may reduce morbidity and mortality in these patients. Additional research is needed to determine effective interventions.

Entities:  

Mesh:

Year:  2006        PMID: 16823016

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  17 in total

1.  Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?

Authors:  F A L E Bracke; L R C Dekker; P H van der Voort; A Meijer
Journal:  Neth Heart J       Date:  2009-03       Impact factor: 2.380

2.  Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication?

Authors:  Daniel Hofer; Jan Steffel; David Hürlimann; Laurent Haegeli; Thomas F Lüscher; Firat Duru; Urs Eriksson; Nazmi Krasniqi
Journal:  J Interv Card Electrophysiol       Date:  2017-11-25       Impact factor: 1.900

3.  Patient expectations from implantable defibrillators to prevent death in heart failure.

Authors:  Garrick C Stewart; Joanne R Weintraub; Parakash P Pratibhu; Marc J Semigran; Janice M Camuso; Kimberly Brooks; Sui W Tsang; Mary Susan Anello; Viviane T Nguyen; Eldrin F Lewis; Anju Nohria; Akshay S Desai; Michael M Givertz; Lynne W Stevenson
Journal:  J Card Fail       Date:  2009-11-04       Impact factor: 5.712

4.  Perceptions of an implantable cardioverter-defibrillator: A qualitative study of families with a history of sudden life-threatening cardiac events and recommendations to improve care.

Authors:  Jarrett Linder; Nadia Hidayatallah; Marina Stolerman; Thomas V McDonald; Robert Marion; Christine Walsh; Siobhan Dolan
Journal:  Einstein J Biol Med       Date:  2013

5.  Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population.

Authors:  S Arnous; N F Murphy; P Pyne-Daly; Z Nawoor; D Keane; M Ledwidge; K McDonald
Journal:  Ir J Med Sci       Date:  2010-12-14       Impact factor: 1.568

6.  Congenital short QT syndrome.

Authors:  Lia Crotti; Erika Taravelli; Giulia Girardengo; Peter J Schwartz
Journal:  Indian Pacing Electrophysiol J       Date:  2010-02-01

7.  Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathy.

Authors:  Man Liu; Lianzhi Gu; Matthew S Sulkin; Hong Liu; Euy-Myoung Jeong; Ian Greener; An Xie; Igor R Efimov; Samuel C Dudley
Journal:  J Mol Cell Cardiol       Date:  2012-11-01       Impact factor: 5.000

8.  An interdisciplinary approach to personalized medicine: case studies from a cardiogenetics clinic.

Authors:  Kathleen E Erskine; Eleanor Griffith; Nicole Degroat; Marina Stolerman; Louise B Silverstein; Nadia Hidayatallah; David Wasserman; Esma Paljevic; Lilian Cohen; Christine A Walsh; Thomas McDonald; Robert W Marion; Siobhan M Dolan
Journal:  Per Med       Date:  2013-01-01       Impact factor: 2.512

9.  Critical appraisal of cardiac implantable electronic devices: complications and management.

Authors:  Luigi Padeletti; Giosuè Mascioli; Alessandro Paoletti Perini; Gino Grifoni; Laura Perrotta; Procolo Marchese; Luca Bontempi; Antonio Curnis
Journal:  Med Devices (Auckl)       Date:  2011-09-09

Review 10.  ICD discrimination of SVT versus VT with 1:1 V-A conduction: A review of the literature.

Authors:  Rhanderson N Cardoso; Chris Healy; Juan Viles-Gonzalez; James O Coffey
Journal:  Indian Pacing Electrophysiol J       Date:  2016-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.